< Back to search trialsA Phase II, Single Arm Study Assessing the Efficacy of Osimertinib in Combination with Savolitinib in Patients with EGFRm+ and MET+, Locally Advanced or Metastatic Non-Small Cell Lung Cancer who have Progressed Following Treatment with Osimertinib (The SAVANNAH Study)
- Clinicaltrials.gov #: NCT03778229
- Acronym: SAVANNAH
- Tumor Type: Lung
- Tumor Subtype: Non-Small Cell Lung Cancer
- Tumor Stage: N/A
- Type of Treatment:
| Institution(s): | PI: | CRC: | |
|---|
| North York General Hospital | Joanne Yu | Alexandra Lostun | Email PI & CRC |
| Odette Cancer Centre | Mark Doherty | Ilda Carvalhana | Email PI & CRC |
